Group-level narrow- and broad-band spectral changes after hemispherotomy reveal a marked EEG slowing of the isolated cortex, robust across patients. by Michele Angelo Colombo (22446342)

Subjects:

The global disease burden of <i><i>Klebsiella pneumoniae</i></i> associated LRI for both sexes in 204 countries and territories. (a) The number of deaths in 2021; (b) The EAPC of d... by Juanjuan Li (399633)

Subjects:

Composition of the gut microbiota at the genus level following the administration of MP. by Yu Sang Choi (22656230)

Subjects:

Composition of the gut microbiota at the phylum level following the administration of MP. by Yu Sang Choi (22656230)

Subjects:

Disruption of hepatic metabolism in Lep KO mice. by Yu Sang Choi (22656230)

Subjects:

Breaking strength and ash contents in the tibia. by Miloš Skřivan (5122037)

Subjects:

Performance characteristics of broilers. by Miloš Skřivan (5122037)

Subjects:

Digesta viscosity and pH in the ileum. by Miloš Skřivan (5122037)

Subjects:

Nutrient retention in broilers (g/kg/day). by Miloš Skřivan (5122037)

Subjects:

Fatty acid composition (mg/100 g) of breast meat. by Miloš Skřivan (5122037)

Subjects:

Fat contents (g/kg) in breast meat and liver. by Miloš Skřivan (5122037)

Subjects:

Raw data. by Saeedeh Abbasi (9423189)

Subjects:

Data. by Saeedeh Abbasi (9423189)

Subjects:

Effects of bevacizumab addition on VEGF-A concentrations <i>in vitro</i>. by Masashi Okawa (8951294)

Subjects:

The characteristics and clinical features of 12 patients. by Masashi Okawa (8951294)

Subjects:

Effect of adding rhVEGF-A (-121 or -165) on the concentrations of VEGF-A121 and VEGF-A165 in plasma samples. by Masashi Okawa (8951294)

Subjects:

Effect of the VEGF-A–bevacizumab complex removal using immunoprecipitation on the concentrations of VEGF-A121, VEGF-A165, and VEGF-A. by Masashi Okawa (8951294)

Subjects:

Equation of the equilibrium dissociation constant of the antigen-antibody reaction. by Masashi Okawa (8951294)

Subjects:

The original data for the figures. by Masashi Okawa (8951294)

Subjects:

Blood concentrations of VEGF-A121, VEGF-A165, and VEGF-A pre- and post-bevacizumab administration. by Masashi Okawa (8951294)

Subjects: